Global Immunosuppressants Market 2022-2026

Report
120 Pages
June 2022
Region: Global
TechNavio
ID: 5632933

The publisher has been monitoring the immunosuppressants market and it is poised to grow by $ 6.99 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. The report on the immunosuppressants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by reimbursement policies for kidney transplantation, rising prevalence of autoimmune diseases, and increasing road accidents. The immunosuppressants market analysis includes the drug class and geographic landscape.

The publisher's immunosuppressants market is segmented as below:

By Drug Class

Corticosteroids
Monoclonal antibodies
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the high dependency on immunosuppressants for kidney transplantation as one of the prime reasons driving the immunosuppressants market growth during the next few years. Also, increase in use of tissue engineering for generation of implants and rise in disposable income in developing economies will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.The report on immunosuppressants market covers the following areas:

Immunosuppressants market sizing
Immunosuppressants market forecast
Immunosuppressants market industry analysis .

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunosuppressants market vendors that include AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc. Also, the immunosuppressants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.uch as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Drug Class

5.1 Market segments
Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
5.2 Comparison by Drug Class
Exhibit 26: Chart on Comparison by Drug Class
Exhibit 27: Data Table on Comparison by Drug Class
5.3 Corticosteroids - Market size and forecast 2021-2026
Exhibit 28: Chart on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Corticosteroids - Year-over-year growth 2021-2026 (%)
5.4 Monoclonal antibodies - Market size and forecast 2021-2026
Exhibit 32: Chart on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Drug Class
Exhibit 40: Market opportunity by Drug Class ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Astellas Pharma Inc.
Exhibit 89: Astellas Pharma Inc. - Overview
Exhibit 90: Astellas Pharma Inc. - Product / Service
Exhibit 91: Astellas Pharma Inc. - Key news
Exhibit 92: Astellas Pharma Inc. - Key offerings
10.4 Bristol Myers Squibb Co.
Exhibit 93: Bristol Myers Squibb Co. - Overview
Exhibit 94: Bristol Myers Squibb Co. - Product / Service
Exhibit 95: Bristol Myers Squibb Co. - Key offerings
10.5 F. Hoffmann La Roche Ltd.
Exhibit 96: F. Hoffmann La Roche Ltd. - Overview
Exhibit 97: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 98: F. Hoffmann La Roche Ltd. - Key news
Exhibit 99: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 100: F. Hoffmann La Roche Ltd. - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 101: GlaxoSmithKline Plc - Overview
Exhibit 102: GlaxoSmithKline Plc - Business segments
Exhibit 103: GlaxoSmithKline Plc - Key news
Exhibit 104: GlaxoSmithKline Plc - Key offerings
Exhibit 105: GlaxoSmithKline Plc - Segment focus
10.7 Intas Pharmaceuticals Ltd.
Exhibit 106: Intas Pharmaceuticals Ltd. - Overview
Exhibit 107: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 108: Intas Pharmaceuticals Ltd. - Key offerings
10.8 Johnson and Johnson
Exhibit 109: Johnson and Johnson - Overview
Exhibit 110: Johnson and Johnson - Business segments
Exhibit 111: Johnson and Johnson - Key news
Exhibit 112: Johnson and Johnson - Key offerings
Exhibit 113: Johnson and Johnson - Segment focus
10.9 Novartis AG
Exhibit 114: Novartis AG - Overview
Exhibit 115: Novartis AG - Business segments
Exhibit 116: Novartis AG - Key offerings
Exhibit 117: Novartis AG - Segment focus
10.10 Pfizer Inc.
Exhibit 118: Pfizer Inc. - Overview
Exhibit 119: Pfizer Inc. - Product / Service
Exhibit 120: Pfizer Inc. - Key news
Exhibit 121: Pfizer Inc. - Key offerings
10.11 Sanofi
Exhibit 122: Sanofi - Overview
Exhibit 123: Sanofi - Business segments
Exhibit 124: Sanofi - Key news
Exhibit 125: Sanofi - Key offerings
Exhibit 126: Sanofi - Segment focus
10.12 Viatris Inc.
Exhibit 127: Viatris Inc. - Overview
Exhibit 128: Viatris Inc. - Business segments
Exhibit 129: Viatris Inc. - Key offerings
Exhibit 130: Viatris Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits 25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Drug Class
Exhibits 27: Data Table on Comparison by Drug Class
Exhibits 28: Chart on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Drug Class ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Astellas Pharma Inc. - Overview
Exhibits 90: Astellas Pharma Inc. - Product / Service
Exhibits 91: Astellas Pharma Inc. - Key news
Exhibits 92: Astellas Pharma Inc. - Key offerings
Exhibits 93: Bristol Myers Squibb Co. - Overview
Exhibits 94: Bristol Myers Squibb Co. - Product / Service
Exhibits 95: Bristol Myers Squibb Co. - Key offerings
Exhibits 96: F. Hoffmann La Roche Ltd. - Overview
Exhibits 97: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 98: F. Hoffmann La Roche Ltd. - Key news
Exhibits 99: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 100: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 101: GlaxoSmithKline Plc - Overview
Exhibits 102: GlaxoSmithKline Plc - Business segments
Exhibits 103: GlaxoSmithKline Plc - Key news
Exhibits 104: GlaxoSmithKline Plc - Key offerings
Exhibits 105: GlaxoSmithKline Plc - Segment focus
Exhibits 106: Intas Pharmaceuticals Ltd. - Overview
Exhibits 107: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits 108: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits 109: Johnson and Johnson - Overview
Exhibits 110: Johnson and Johnson - Business segments
Exhibits 111: Johnson and Johnson - Key news
Exhibits 112: Johnson and Johnson - Key offerings
Exhibits 113: Johnson and Johnson - Segment focus
Exhibits 114: Novartis AG - Overview
Exhibits 115: Novartis AG - Business segments
Exhibits 116: Novartis AG - Key offerings
Exhibits 117: Novartis AG - Segment focus
Exhibits 118: Pfizer Inc. - Overview
Exhibits 119: Pfizer Inc. - Product / Service
Exhibits 120: Pfizer Inc. - Key news
Exhibits 121: Pfizer Inc. - Key offerings
Exhibits 122: Sanofi - Overview
Exhibits 123: Sanofi - Business segments
Exhibits 124: Sanofi - Key news
Exhibits 125: Sanofi - Key offerings
Exhibits 126: Sanofi - Segment focus
Exhibits 127: Viatris Inc. - Overview
Exhibits 128: Viatris Inc. - Business segments
Exhibits 129: Viatris Inc. - Key offerings
Exhibits 130: Viatris Inc. - Segment focus
Exhibits 131: Inclusions checklist
Exhibits 132: Exclusions checklist
Exhibits 133: Currency conversion rates for US$
Exhibits 134: Research methodology
Exhibits 135: Validation techniques employed for market sizing
Exhibits 136: Information sources
Exhibits 137: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global immunosuppressants market: AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc.

Commenting on the report, an analyst from the publishing company said: "The latest trend gaining momentum in the market is high dependency on immunosuppressants for kidney transplantation."

According to the report, one of the major drivers for this market is the reimbursement policies for kidney transplantation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
Accord Healthcare Ltd.
Astellas Pharma Inc.
Belcher Pharmaceuticals LLC
Bristol Myers Squibb Co.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Intas Pharmaceuticals Ltd.
Johnson and Johnson
LEO Pharma AS
Livzon Pharmaceutical Group Inc.
Novartis AG
Pfizer Inc.
RPG Life Sciences Ltd.
Sanofi
Sebela Pharmaceuticals Inc.
TFF Pharmaceuticals Inc.
Viatris Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2408EUR$2,500USD£2,071GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4815EUR$5,000USD£4,141GBP

By Drug Class

By Geographical Landscape

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Immunosuppressants - Global Strategic Business Report

Global Heart Transplantation Therapeutics Market 2024-2028

Global HIV Drugs Market

Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Immunosuppressants Global Market Report 2024